AOI Online Chat

Dr Kunal Jain

  • Dr. Kunal Jain has completed MBBS in 1999 from Christian Medical College & Hospital, Ludhiana.
  • MD Internal Medicine in 2004 from Christian Medical College & Hospital, Ludhiana.
  • DNB-Internal Medicine in 2005)
  • MNAMS – Member of National Academy of Medical Sciences in 2006.
  • ECMO – ESMO Certified Medical Oncologist since 2007.
  • Senior Registrar in Medical Oncology at Tata Memorial Hospital, Mumbai, Sept. 2006 – Mar. 2007.
  • Senior Registrar Medical Oncology at Royal Adelaide Hospital, Adelaide, South Australia, Australia, Apr. 2008 to Feb. 2010.
  • Clinical Research Fellow in Medical Oncology Unit at Flinders Medical Centre, Bedford Park, South Australia, Australia, Feb 2010 to Feb 2011.
  • CCPPM (Certified Course in Pain and Palliative Medicine) Completed 6 weeks training in pain and palliative care course organized by Trivandrum Institute of Palliative Sciences (TIPS), Pallium India, Trivandrum (2012).
  • Punjab Medical Council (Reg. No 31301) – Since 2000.
  • Conditional Annual Practicing Certificate for Medical Board of Northern Territory (Reg. No 1082072) – Nov. 2009 – Nov. 2010.
  • Association of Physicians of India (API), 2006.
  • Indian Medical Association (IMA), 2007.
  • Indian Co-operative Oncology Network (ICON), 2007.
  • European Society of Medical Oncology (ESMO), 2007.
  • Cooperative Trials Group for Neuro-Oncology (COGNO), 2009.
  • Australasian Lung Cancer Trials Group (ALTG), 2009.
  • American Society of Medical Oncology (ASCO), 2010.
  • Indian Association of Palliative Care (IAPC), 2012.
  • Founder Member of “Can Fight Cancer” – An NGO registered in 2013.
  • Member of Indo-American Cancer Association (IACA), 2014
  • Jun. 2014 – Mar. 2017:
    Assistant Professor, Department of Medical Oncology, Dayanand Medical College and Hospital, Tagore Nagar, Ludhiana 141001.
  • Feb. 2014 – Jun. 2014:
    Associate Professor, Department of Medicine, Head Medical Oncology Unit, Christian Medical College and Hospital, Ludhiana 141008.
  • Feb. 2011 – Feb. 2014:
    Assistant Professor, Department of Medicine, Head Medical Oncology Unit, Christian Medical College and Hospital, Ludhiana 141008.
  • Feb. 2010 – Feb. 2011:
    Research Fellow, Department of Medical Oncology (Clinical Trials), Flinders Medical Centre, Bedford Park, SA 5042.
  • Apr. 2008 – Feb. 2010:
    Senior Registrar, Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, SA 5000.
  • July 2007- Mar. 2008:
    Junior Consultant in Mohan Dai Oswal Cancer Treatment and Research Foundation, Ludhiana, Punjab 141009.
  • Mar. 2007- July 2007:
    Assistant Professor, Department of Medicine, Christian Medical College and Hospital, Ludhiana, Punjab 141008.
  • Sep. 2006 – Feb. 2007:
    Senior Registrar, Department of Medical Oncology, Tata Memorial Hospital, Mumbai, 400012.
  • May 2005 – Sep. 2006:
    Lecturer, Dept. of Medicine, Christian Medical College and Hospital, Ludhiana, Punjab 141008.
  • Jan. 2005 – Apr. 2005:
    Senior Resident, Dept. of Medicine, Christian Medical College and Hospital, Ludhiana, Punjab 141008.
  • Jul 2001 – Dec 2001:
    Demonstrator, Dept. of Anatomy, Christian Medical College and Hospital, Ludhiana, Punjab 141008.
  • Jan 2000 – Jun 2001:
    Non PG resident, Dept. of Cardiology, Christian Medical College and Hospital, Ludhiana, Punjab 141008

International Journals:

  • Original study titled “A Population-Based Study of Metastatic Colorectal Cancer (mCRC) in People Aged ≥80; findings from The South Australian Clinical Registry (SACR) for mCRC.” Cancer 2013 Feb. 15;119(4):722-8. (doi: 10.1002/cncr.27802. Epub 2012 Sep. 18)
  • Rechallenge with oxaliplatin and fluoropyrimidine for metastatic colorectal carcinoma after prior therapy. Townsend AR, Bishnoi S, Broadbridge V, Beeke C, Karapetis CS, Jain K, Luke C, Padbury R, Price TJ. Am J Clin Oncol. 2013 Feb.;36(1):49-52. (doi: 10.1097/COC.0b013e31823fe40e).
  • Original Study titled “Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies” published in Support Care Cancer 2014 Jan.;22(1):121-8. (doi:10.1007/s00520-013-1941-1, Epub 2013 Sep. 5)
  • Original Study titled “Colorectal Cancer Survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumour” published in Clinical Colorectal Cancer 2014 Jun.;13(2):87-93 (http://dx.doi.org/10.1016/j.clcc.2013.11.008).
  • “Survival of Triple Negative versus Triple Positive Breast Cancers: Comparison and Contrast” (Authors – Preety Negi, Pamela Alice Kingsley, Kunal Jain, Jaineet Sachdeva, Himanshu Srivastava, Sudeep Marcus, Aman Pannu) published in Asian Pacifc Journal of Cancer Prevention 2016;17(8):3909-3914

National Journals:

  • Erythropoietin use and abuse. John MJ, Jaison V, Jain K, Kakkar N, Jacob J. Indian J Endocr Metab 2012;16:220-227.
  • Paper titled “Effect of Complete Decongestive Therapy (CDT) in upper limb lymphedema in breast cancer patients” published in Indian Journal of Physiotherapy and Occupational Therapy. Mullai Dhinakaran, Kunal Jain, K E Benjamin, Paramdeep Kaur, Dhinakaran. IJPOT 2014 (Oct. – Dec.), Vol 8; No 4; Page 87.
  • Case Report – “Progressive Nodular Histiocytosis Associated with Eale’s Disease” Abhilasha Williams, Abraham G Thomas, Kanwardeep Singh Kwatra, Kunal Jain published in Indian Journal of Dermatology, Vol 60, Issue 4 (July – August 2015), Pg 388 – 390.
  • IJD Sun Award 2015 for best case report for “Progressive Nodular Histiocytosis Associated with Eale’s Disease”

International

  • June 2007: “Outcome of patients of CML in AP and BC with Imatinib: A retrospective analysis of patients from India.” Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 25, No 18S (June 20 Supplement), 2007: Abstract 17531.
  • May 2008: “Treatment outcomes in patients with extensive stage small cell lung cancer – Experience from a tertiary Indian cancer centre” Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 26, No 15S (May 20 Supplement), 2008: Abstract 19129.
  • 12th Aug 2010 – Poster presentation at MOGA 2010 Annual meeting, Sydney (Abstract ID: 16) “Toxicity and patient tolerance of Oxaliplatin (FOLFOX) based treatment for colo-rectal cancer and their subsequent management – Retrospective audit of patterns of care in two major cancer centers in Adelaide”, Asia–Pac J Clin Oncol 2010; 6(Suppl. 2): 53–60.
  • 10th Oct. 2010 – Poster presentation at 35th ESMO Congress, Milan (Abstract ID: 4326/ Poster: 1260P): “A randomized trial comparing peripherally inserted central venous catheters (PICC) vs subcutaneously implanted port-chamber catheters (PORT) for delivery of chemotherapy to patients with non-haematological malignancies”.
  • 9th Nov. 2010 – Poster presentation at COSA 2010 annual meeting, Melbourne (Abstract ID: 323): “A randomized trial comparing two types of chronic indwelling central venous catheter (CVC) devices used for the delivery of chemotherapy to patients with non-haematological malignancy – Peripherally Inserted Central Venous Catheters (PICC) vs subcutaneously implanted Port-chamber catheters (PORT).”
  • Jan. 2011 – Poster presentation at ASCO GI 2011 annual meeting, San Francisco (Abstract ID: 514): “A population-based study of metastatic colorectal cancer (mCRC) in people age 80 and older: Findings from the South Australian Clinical Registry (SACR) for mCRC.”
  • Jun. 2011 – Poster presentation at ASCO 2011, Chicago (Permanent Abstract ID: 9082). Abstract Title: A population-based study of metastatic colorectal cancer (mCRC) in people age 80 or older: Findings from the South Australian Clinical Registry (SACR) for mCRC.
  • July 2011 – Poster presentation at 14th WCLC, Amsterdam (Abstract ID: 2038): “Concurrent Chemo-radiotherapy (CRT) for Localized Unresectable Non-Small Cell Lung Cancer (NSCLC): 10-year Experience from an Australian General Teaching Hospital” – Kunal Jain, M Ly, J Leung, B Koczwara, S Sukumaran, G Kichenadasse, K Jain, T Woo, A Khattak, S Bishnoi, A Richards, C S Karapetis: Published in Journal of Thoracic Oncology; Vol 6, No 6, Supp 2, June 2011; S1552.
  • June 2012: Abstract accepted for publication in 2012 ASCO annual meeting: “Variations in serum Vit D status during cancer chemotherapy”: B Koczwara, R J Woodman, L V Teleni, M Kimlin, E T Walpole, K Jain, C S Karapetis, E L Smith, W L Davidson, M Ferguson, S Sukumaran, G Kichenadasse, E Isenring (Abstract ID: e19550).
  • July 2012 – Abstract “ Efficacy of Influenza vaccine (FLUVAX) in patients undergoing chemotherapy” accepted for poster presentation at 37th ESMO Congress 2012 at Vienna in September 2012 (Abstract ID: 2969).
  • Abstract “Effectiveness of complete decongestive therapy (CDT) in managing secondary lymphedema after modified radical mastectomy (MRM)” accepted for publication in 2012 ASCO annual meeting: K Jain, M Dhinakaran, K E Benjamin (Abstract ID: e19622)

National

  • June 2007: “Outcome of patients of CML in AP and BC with Imatinib: A retrospective analysis of patients from India.” Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 25, No 18S (June 20 Supplement), 2007: Abstract 17531.
  • May 2008: “Treatment outcomes in patients with extensive stage small cell lung cancer – Experience from a tertiary Indian cancer centre” Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 26, No 15S (May 20 Supplement), 2008: Abstract 19129
  • Poster presentation at 52nd Conference of the Indian Society of Haematology and blood transfusion, PGI Chandigarh, November 10-12, 2011: Fludarabine induced autoimmune Haemolytic Anaemia (AIHA) in a patient with chronic lymphocytic leukemia (CLL) and subsequent management with Bendamustine/Rituximab (BR). KE Cherian, MJ John, CC Philip, K Jain, N Kakkar, R Kaur (P 071).
  • Poster presentation at 52nd Conference of the Indian Society of Haematology and blood transfusion, PGI Chandigarh, November 10-12, 2011: Differential cooling and condensation of water on the ceiling as a cause of fungal growth resulting in potential incidence of fungal infection. MJ John, J Cherian, M Chandy, SM John, N Kakkar, K Jain, A Isaiah (P 221).
  • Poster presentation at 52nd Conference of the Indian Society of Haematology and blood transfusion, PGI Chandigarh, November 10-12, 2011: Recombinant Human Erythropoietin Induced Pure Red Cell Aplasia in a patient with chronic renal failure– A Case Report. MJ John, Vineeth Jaison, R Issac, K Jain, N Kakkar. (P 270).
  • Poster presentation at 52nd Conference of the Indian Society of Haematology and blood transfusion, PGI Chandigarh, November 10-12, 2011: Two cases of Vinca Alkaloid Extravasation and its management. Tanuja, D Gupta, AF Masih, K Jain, MJ John. (P 334).
  • Poster presentation at 52nd Conference of the Indian Society of Haematology and blood transfusion, PGI Chandigarh, November 10-12, 2011: Unusual presentation of Non Hodgkin’s Lymphoma (NHL) posing diagnostic challenge. Shubhda Garg, K Jain, K Kwatra, J Cotelingam, A Lazarus, MJ John. (P 091)
  • Poster presentation at 52nd Conference of the Indian Society of Haematology and blood transfusion, PGI Chandigarh, November 10-12, 2011: Sixteen years with Chronic Myeloid Leukemia (CML) and more than 10 years on Imatinib: Clinical and side effects profile in a patient. KE Cherian, MJ John, K Jain, N Kakkar. (P 070)
  • Poster presentation at 1st Indian Cancer Congress, New Delhi (November 21 – 24, 2013): Pattern of presentation and management of advanced biliary tract cancers – Single Institution experience. (Abstract ID: 1714). Published in Indian Journal of Cancer Nov. 2013; vol 50; Supp1:S126.
  • Poster presentation at 1st Indian Cancer Congress, New Delhi (November 21 – 24, 2013): Progressive Nodular Histiocytosis: A rare cause of progressive cutaneous masses in a young male. (Abstract ID: 1090). Published in Indian Journal of Cancer Nov 2013; vol 50; Supp1:S179.
  • Poster presentation at 1st Indian Cancer Congress, New Delhi (November 21 – 24, 2013): Sequential use of Rituximab and Trastuzumab in a patient with two separate malignancies. (Abstract ID: 1092). Published in Indian Journal of Cancer Nov 2013; vol 50; Supp1:S180.
  • Poster presentation at 1st Indian Cancer Congress, New Delhi (November 21 – 24, 2013): Knowledge and beliefs regarding cervical cancer among Punjabi rural women – a cross sectional study. (Abstract ID: 1397). Published in Indian Journal of Cancer Nov 2013; vol 50; Supp1:S309
  • Jan. 2001- Jun. 2001: Research Assistant in CREATE REGISTRY, Dept. of Cardiology, CMCH, Ludhiana.
  • Jul. 2002 – Jun. 2004: Thesis on “Role of serum Myoglobin in diagnosis and prognosis of Acute Coronary Syndromes”, Dept. of Medicine and Cardiology, CMCH, Ludhiana.
  • Apr. 2008 – Feb. 2010: Sub-investigator in various oncology clinical trials (including phase I oncology trials) conducted at Royal Adelaide Hospital, Adelaide, SA 5000.
  • Feb. 2010 – Feb. 2011: Sub-investigator in various oncology clinical trials conducted at Flinders Medical Centre, Bedford Park, SA 5042.
  • Jan. 2011 – Completed ARCS online GCP training (Australia).
  • 2012 – Supervisor and guide for a research project titled “Knowledge and beliefs regarding cervical cancer, its screening and prevention among rural women in two villages of Punjab” completed by MBBS student (Dr Jibi John) after approval from ICMR (Reference ID 2012-02998).